Rhythm Pharmaceuticals, Inc.
RYTM
$90.51
$3.133.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.73% | -21.13% | -44.55% | 64.99% | -3.98% |
| Total Depreciation and Amortization | -28.98% | -21.04% | -2.82% | -5.43% | -8.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 62.64% | 70.99% | 272.70% | -83.72% | 373.87% |
| Change in Net Operating Assets | -106.77% | -33.91% | 310.86% | -261.47% | 14.58% |
| Cash from Operations | -34.73% | -5.58% | 19.82% | 0.96% | 35.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.94% | -171.25% | 731.10% | -17.43% | -6.55% |
| Cash from Investing | 43.44% | -171.25% | 731.10% | -17.43% | -6.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.18% | 3,243.70% | 145.58% | 428.24% | 743.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -41.81% | -66.97% | -173.09% | -65.83% | -47.94% |
| Cash from Financing | -107.69% | 7,496.35% | -100.61% | 665.94% | 1,481.84% |
| Foreign Exchange rate Adjustments | -93.45% | 150.41% | 7.31% | 97.18% | 608.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.02% | 26.97% | -72.70% | 360.05% | 1,022.38% |